# Lisdexamfetamine for Adults With Bulimia Nervosa

> **NCT03397446** · PHASE2 · TERMINATED · sponsor: **Aaron Keshen** · enrollment: 23 (actual)

## Conditions studied

- Bulimia Nervosa

## Interventions

- **DRUG:** Lisdexamfetamine dimesylate

## Key facts

- **NCT ID:** NCT03397446
- **Lead sponsor:** Aaron Keshen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-21
- **Primary completion:** 2020-05-19
- **Final completion:** 2020-05-19
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Loss of resources due to COVID-19 resulted in insufficient funds to complete the trial as planned. However, sufficient data was collected to fulfill the aims of the trial. Discontinuation is not related to the drug, its use, or adverse events.
- **Last updated:** 2020-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03397446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03397446, "Lisdexamfetamine for Adults With Bulimia Nervosa". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03397446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*